A Scottish court's rejection of an appeal by the insurance industry against legislation supporting compensation for pleural plaques is a landmark development for asbestos-related disease (ARD) healthcare, on various levels. On the one hand, it recognises the potential seriousness of ...
Please Login to read the full article.
